Literature DB >> 20031332

Approach to radiation therapy in hepatocellular carcinoma.

Shumei Ma1, Benzheng Jiao, Xin Liu, Heqing Yi, Dejuan Kong, Lin Gao, Guangtong Zhao, Yu Yang, Xiaodong Liu.   

Abstract

Hepatocellular carcinoma (HCC), the 5th most common cancer and the third most common cause of cancer-related death in the world with an estimated incidence of approximately 1 million new cases annually, has becoming a major global health problem in the world. A variety of treatment modalities, including resection, liver transplantation, transarterial chemoembolization (TACE), local ablative therapy and radiation therapy (RT) have been reported. Although partial hepatectomy and liver transplantation may offer the best chance of cure, only 15% of the patients have the chance to be treated by surgery when diagnosed. The effectiveness of systemic chemotherapy for HCC has been minimal, and local ablative therapy may offer comparable survival in patients with small HCC and preserve liver function. Recently, with developments in radiotherapy techniques, radiotherapy has been shown to play potential roles in a wide spectrum of HCC and to become more important so that it is necessary to evaluate the effect of radiotherapy in treatment of HCC. This paper is aiming mainly at the current radiation therapy strategies and their current advances, the optimal radiation therapy strategies will complement the current treatments and improve the treatment efficiency. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031332     DOI: 10.1016/j.ctrv.2009.11.008

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  17 in total

1.  Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells.

Authors:  M He; M Zhao; B Shen; K M Prise; C Shao
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

2.  Concomitant lung metastasis in patients with advanced hepatocellular carcinoma.

Authors:  Tian Yang; Jun-Hua Lu; Chuan Lin; Song Shi; Ting-Hao Chen; Rong-Hua Zhao; Yi Wang; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

3.  SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.

Authors:  Qianping Chen; Wang Zheng; Jian Guan; Hongxia Liu; Yao Dan; Lin Zhu; Yimeng Song; Yuchuan Zhou; Xinrui Zhao; Yuhong Zhang; Yang Bai; Yan Pan; Jianghong Zhang; Chunlin Shao
Journal:  Cell Death Differ       Date:  2022-08-22       Impact factor: 12.067

4.  Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo.

Authors:  Yanling Yang; Cheng Jin; Haimin Li; Yong He; Zhaohui Liu; Ling Bai; Kefeng Dou
Journal:  Exp Ther Med       Date:  2011-11-24       Impact factor: 2.447

5.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

6.  Scheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinoma.

Authors:  Jeong Il Yu; Hee Chul Park; Do Hoon Lim; Cheol Jin Kim; Dongryul Oh; Byung Chul Yoo; Seung Woon Paik; Kwang Cheol Kho; Joon Hyuk Lee
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

7.  Sequential transcatheter arterial chemoembolization, three-dimensional conformal radiotherapy, and high-intensity focused ultrasound treatment for unresectable hepatocellular carcinoma patients.

Authors:  Shengfa Ni; Lingxiang Liu; Yongqian Shu
Journal:  J Biomed Res       Date:  2012-04-10

8.  Particle radiotherapy with carbon ion beams.

Authors:  Tatsuya Ohno
Journal:  EPMA J       Date:  2013-03-04       Impact factor: 6.543

9.  Dosimetric differences among volumetric modulated arc radiotherapy (RapidArc) plans based on different target volumes in radiotherapy of hepatocellular carcinoma.

Authors:  GuanZhong Gong; Yong Yin; YuJie Guo; TongHai Liu; JinHu Chen; Jie Lu; ChangSheng Ma; Tao Sun; Tong Bai; GuiFang Zhang; DengWang Li; RuoZheng Wang
Journal:  J Radiat Res       Date:  2012-08-21       Impact factor: 2.724

10.  CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation.

Authors:  Hai-yan Chen; Xiu-Mei Ma; Ming Ye; Yan-li Hou; Bin Hu; Yong-rui Bai
Journal:  J Radiat Res       Date:  2013-04-24       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.